TY - JOUR
T1 - Prostate cancer
T2 - state of the art imaging and focal treatment
AU - Woodrum, D. A.
AU - Kawashima, A.
AU - Gorny, K. R.
AU - Mynderse, L. A.
N1 - Publisher Copyright:
© 2017
PY - 2017/8
Y1 - 2017/8
N2 - In 2016, it is estimated 180,890 men are newly diagnosed with prostate cancer and 3,306,760 men live with prostate cancer in the United States. The introduction of multiparametric (mp) magnetic resonance imaging (MRI) of the prostate, standardised interpretation guidelines such as Prostate Imaging Reporting and Data System (PI-RADS version 2), and MRI-based targeted biopsy has improved detection of clinically significant prostate cancer. Accurate risk stratification (Gleason grade/score and tumour stage) using imaging and image-guided targeted biopsy has become critical for the management of patients with prostate cancer. Recent advances in MRI-guided minimally invasive ablative treatment (MIAT) utilising cryoablation, laser ablation, high-intensity focused ultrasound ablation, have allowed accurate focal or regional delivery of optimal thermal energy to the biopsy proven, MRI-detected tumour, under real-time or near simultaneous MRI monitoring of the ablation zone. A contemporary review on prostate mpMRI, MRI-based targeted biopsy, and MRI-guided ablation techniques is presented.
AB - In 2016, it is estimated 180,890 men are newly diagnosed with prostate cancer and 3,306,760 men live with prostate cancer in the United States. The introduction of multiparametric (mp) magnetic resonance imaging (MRI) of the prostate, standardised interpretation guidelines such as Prostate Imaging Reporting and Data System (PI-RADS version 2), and MRI-based targeted biopsy has improved detection of clinically significant prostate cancer. Accurate risk stratification (Gleason grade/score and tumour stage) using imaging and image-guided targeted biopsy has become critical for the management of patients with prostate cancer. Recent advances in MRI-guided minimally invasive ablative treatment (MIAT) utilising cryoablation, laser ablation, high-intensity focused ultrasound ablation, have allowed accurate focal or regional delivery of optimal thermal energy to the biopsy proven, MRI-detected tumour, under real-time or near simultaneous MRI monitoring of the ablation zone. A contemporary review on prostate mpMRI, MRI-based targeted biopsy, and MRI-guided ablation techniques is presented.
UR - http://www.scopus.com/inward/record.url?scp=85016603173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016603173&partnerID=8YFLogxK
U2 - 10.1016/j.crad.2017.02.010
DO - 10.1016/j.crad.2017.02.010
M3 - Review article
C2 - 28385253
AN - SCOPUS:85016603173
SN - 0009-9260
VL - 72
SP - 665
EP - 679
JO - Clinical Radiology
JF - Clinical Radiology
IS - 8
ER -